bpc-157 e tb-500 and TB-500: Injury Healing Peptides | Jonathan L. Glashow posted on the topic BPC-157 & TB-500 Mix

Subcutaneous depots above 1 mL create visible subcutaneous nodules and increase the risk of incomplete absorption as the depot exceeds local capillary uptake capacity

Mller, T

Active principles: Enrofloxacino Target species: Goat, Cats, Ovine, Dogs, Porcine, Calves Laboratory: Bayer Animal Health Gmbh Prescription: You need a prescription Data sheet Pharmaceutical form Injectable solution Administration routes Intramuscular via Intravenously Subcutaneous via Dose * 1 ml/10 kg p.v

Shaking creates foam and can denature the peptide

Participants were a asked about physical activity within the last week, and those who were inactive for the full 7 d were defined as having low physical activity, compared with moderate (active 13 d) and high (active 4 or more days) physical activity